Neovasc develops, manufactures and markets innovative vascular devices. Our products include the Neovasc Reducer™ for refractory angina and PeriPatch™ surgical tissue.
We also offer pericardial tissue processing, vascular product development, design and manufacturing solutions to industry partners.
Neovasc is headquartered in Vancouver, Canada. Our products are approved for sale and distribution worldwide.
Neovasc was formed on July 1, 2008. Canadian device firm Medical Ventures Corp. acquired two Israeli development-stage device companies, Neovasc Medical Ltd. and B-Balloon Ltd.
Investor contacts
Investors-USA
GendelLindheim BioCom Partners
Barbara Lindheim
Email: blindheim@biocompartners.com
Phone: 212.918.4650
Investors-Canada
Email: investors@neovasc.com
